MP43-18 PROSTATE CANCER MORTALITY RATES IN LOW AND FAVORABLE INTERMEDIATE RISK ACTIVE SURVEILLANCE PATIENTS: A POPULATION-BASED COMPETING RISKS ANALYSIS. (1st May 2022)